Fentanyl for the relief of refractory breathlessness: A systematic review

Journal of Pain and Symptom Management

Volumn 46, Issue 6, 2013, Pages 874-886

  Simon, Steffen T ^a   Köskeroglu, Peyla ^a   Gaertner, Jan ^b   Voltz, Raymond ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Dyspnea; fentanyl; palliative; systematic review

Indexed keywords

FENTANYL; PLACEBO;

BREATHING RATE; CLINICAL TRIAL; DIZZINESS; DRUG EFFICACY; DYSPNEA; HUMAN; OXYGEN SATURATION; PATIENT SATISFACTION; RESPIRATION DEPRESSION; REVIEW; SOMNOLENCE; SYSTEMATIC REVIEW;

DYSPNEA; FENTANYL; PALLIATIVE; SYSTEMATIC REVIEW;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; CHRONIC DISEASE; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; DYSPNEA; EVIDENCE-BASED MEDICINE; FEMALE; FENTANYL; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PREVALENCE; RECURRENCE; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84888638352     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2013.02.019     Document Type: Review

References (32)

1. M.B. Parshall, R.M. Schwartzstein, and L. Adams An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea Am J Respir Crit Care Med 185 2012 435 452
2. S. Booth, S. Silvester, and C. Todd Breathlessness in cancer and chronic obstructive pulmonary disease: using a qualitative approach to describe the experience of patients and carers Palliat Support Care 1 2003 337 344
3. M. Gysels, C. Bausewein, and I. Higginson Experiences of breathlessness: a systematic review of the qualitative literature Palliat Support Care 5 2007 281 302
4. D. Reuben, and V. Mor Dyspnea in terminally ill cancer patients Chest 89 1986 234 236
5. D.C. Currow, J.L. Plummer, A. Crockett, and A.P. Abernethy A community population survey of prevalence and severity of dyspnea in adults J Pain Symptom Manage 38 2009 533 545
6. N. Altfelder, F. Nauck, B. Alt-Epping, C. Bausewein, and S.T. Simon Characteristics of patients with breathlessness - a German national survey on palliative care in-patient units [Abstract] Palliat Med 24 2010 S37
7. S. Booth, C. Bausewein, I. Higginson, and S.H. Moosavi Pharmacological treatment of refractory breathlessness Expert Rev Respir Med 3 2009 21 36
8. S.K. Reddy, H.A. Parsons, A. Elsayem, J.L. Palmer, and E. Bruera Characteristics and correlates of dyspnea in patients with advanced cancer J Palliat Med 12 2009 29 36
9. A.L. Jennings, A.N. Davies, J.P. Higgins, and K. Broadley Opioids for the palliation of breathlessness in terminal illness Cochrane Database Syst Rev 4 2001 CD002066
10. A.P. Abernethy, D.C. Currow, and P. Frith Randomised, double blind, placebo-controlled crossover trial of sustained release morphine for the management of refractory dyspnoea BMJ 327 2003 1 6
11. S.T. Simon, I.J. Higginson, and H. Benalia Episodic and continuous breathlessness - a new categorization of breathlessness J Pain Symptom Manage 45 2013 1019 1029
12. E. Freye, J.V. Levy, and D. Braun Effervescent morphine results in faster relief of breakthrough pain in patients compared to immediate release morphine sulfate tablet Pain Pract 7 2007 324 331
13. A. Davies, G. Zeppetella, and S. Andersen Multi-centre European study of breakthrough cancer pain: pain characteristics and patient perceptions of current and potential management strategies Eur J Pain 15 2011 756 763
14. A.N. Davies, A. Dickman, C. Reid, A.M. Stevens, and G. Zeppetella The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland Eur J Pain 13 2009 331 338
15. M.P. Davis Fentanyl for breakthrough pain: a systematic review Expert Rev Neurother 11 2011 1197 1216
16. A. Liberati, D.G. Altman, and J. Tetzlaff The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration J Clin Epidemiol 62 2009 e1 e34
17. M.A. Benitez-Rosario Oral transmucosal fentanyl citrate in the management of dyspnea crises in cancer patients J Pain Symptom Manage 30 2005 395 397
18. M. Burburan Effects of nebulised fentanyl in patients with refractory dyspnea Eur J Palliat Care 39 2009 (Abstract FC02.3)
19. P.J. Coyne Nebulized fentanyl citrate improves patients' perception of breathing, respiratory rate, and oxygen saturation in dyspnea J Pain Symptom Manage 23 2002 157 160
20. A.A. Gauna, S.K. Kang, M.L. Triano, E.R. Swatko, and V.J. Vanston Oral transmucosal fentanyl citrate for dyspnea in terminally ill patients: an observational case series J Palliat Med 11 2008 643 648
21. M. Gika, K. Eguchi, and Y. Inoue Successful management of a patient with pain and dyspnea from bone metastasis and lymphangitis carcinomatosa after surgery for non-small cell lung cancer (NSCLC) in whom optimal dosages of transdermal fentanyl were determined by titration with fentanyl injection, and oxycodone hydrochloride. [in Japanese] Gan to kagaku ryoho (Cancer & Chemotherapy) 37 2010 547 550
22. G. Graff Nebulized fentanyl for palliation of dyspnea in a cystic fibrosis patient Respiration 71 2004 646 649
23. D. Jensen, A. Alsuhail, and R. Viola Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease J Pain Symptom Manage 43 2012 706 719
24. S. Mercadante The use of remifentanil in palliative care J Pain Symptom Manage 17 1999 387 388
25. L. O'Siorain Transdermal fentanyl in palliative care. A series of five cases Clin Drug Investig 16 1998 88 91
26. T.J. Smith Failure to accrue to a study of nebulized fentanyl for dyspnea: lessons learned J Palliat Med 12 2009 771 772
27. R. Trujillo Vilchez, N. Morgado Bermejo, and A. Ortega Morell Dyspnea improvement following treatment with oral transmucosal fentanyl citrate in a patient with advanced lung cancer. [in Spanish] Medicina Paliativa 12 2005 194 196
28. T. Sitte, and C. Bausewein Intranasal fentanyl for episodic breathlessness J Pain Symptom Manage 36 2008 e3 e6
29. T. Sitte Nasal application of fentanyl citrate as symptom control against breathlessness in palliative care: overview and case report. [in German] Wien Med Wochenschr 159 2009 566 570
30. S. Mercadante, P. Ferrera, C. Adile, and A. Casuccio Fentanyl buccal tablets for breakthrough pain in highly tolerant cancer patients: preliminary data on the proportionality between breakthrough pain dose and background dose J Pain Symptom Manage 42 2011 464 469
31. D.C. Currow, C. McDonald, and S. Oaten Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study J Pain Symptom Manage 42 2011 388 399
32. K.E. Clemens, and E. Klaschik Symptomatic therapy of dyspnea with strong opioids and its effect on ventilation in palliative care patients J Pain Symptom Manage 33 2007 473 481